Thomas Puyregner
About Thomas Puyregner
Thomas Puyregner is the Senior Director, Study Start-Up Head Europe at BeiGene, with a background in clinical trial operations and a focus on improving productivity and engagement.
Title and Current Position
Thomas Puyregner currently holds the position of Senior Director, Study Start-Up Head Europe at BeiGene. He operates out of the Greater Paris Metropolitan Region. In this role, Thomas is responsible for overseeing the study start-up processes across Europe, ensuring efficient and timely initiation of clinical trials.
Previous Roles and Experience
Thomas Puyregner has accumulated a wealth of experience in the pharmaceutical and biotechnology industries. Prior to his current role at BeiGene, he served as Senior Director, Global Head Monitoring at Innovent Biologics for 9 months from 2022 to 2023. Before Innovent Biologics, Thomas worked at Novartis in several significant roles including Director, Project Management Office at Trial Monitoring (2020-2022), Global Head, Trial Operations Management Oncology a.i. (2019-2020), and Development Unit Head, Trial Operations Management - Oncology (2017-2020). Early in his career, he worked as a Genotype Analyst at Genset from 1999 to 2000.
Education and Academic Background
Thomas Puyregner has a solid academic foundation in the fields of molecular biology and pharmacy. He earned a Master’s degree in Molecular Biology from IUT Nancy, where he studied from 1994 to 1996. Additionally, he completed a one-year Drug Design program at the University of Pharmacy Lille, achieving a DU in 1997.
Operational and Leadership Skills
Throughout his career, Thomas Puyregner has demonstrated significant skills in improving productivity by optimizing operational workflows and processes in clinical trials. He is passionate about building, training, mentoring, and developing employees' careers. Known for his ability to bridge the gap between people, processes, innovations, and technologies, Thomas consistently works to enhance performance and engage people more effectively.
Focus on Clinical Trials
Thomas Puyregner has a strong focus on making clinical trials faster and easier for patients, sites, and industries. His efforts have been directed toward streamlining workflows and adopting innovative solutions to expedite the clinical trial process. This focus not only improves efficiency but also aims to enhance the overall experience for all stakeholders involved in clinical trials.